Cutaneous intralymphatic anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma arising in a patient with multiple rounds of breast implants

J Cutan Pathol. 2021 May;48(5):659-662. doi: 10.1111/cup.13936. Epub 2020 Dec 22.

Abstract

Primary cutaneous anaplastic large-cell lymphoma and breast implant-associated ALCL (BIA-ALCL) are rare subtypes of anaplastic lymphoma kinase (ALK)-negative ALCLs originating from skin and breast implants, respectively. Herein, we report a unique case of cutaneous ALK-negative ALCL occurring in the skin of left medial breast from a patient with multiple rounds of bilateral breast implants and a history of breast carcinoma. The lymphoma cells are entirely confined to the lymphatic channels in the dermis, and the patient has no other areas of skin abnormality, no lymphadenopathy, peri-implant fluid accumulation, or masses from the bilateral capsules of implants. The differential diagnosis and its relationship with breast implants are further explored.

Keywords: anaplastic large-cell lymphoma; anaplastic lymphoma kinase; breast implant.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anaplastic Lymphoma Kinase / metabolism
  • Aromatase Inhibitors / administration & dosage
  • Aromatase Inhibitors / therapeutic use
  • Biopsy
  • Breast Implants / adverse effects*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / secondary
  • Breast Neoplasms / surgery*
  • Diagnosis, Differential
  • Female
  • Humans
  • Ki-67 Antigen / metabolism
  • Lymphatic Vessels / pathology
  • Lymphoma, Large-Cell, Anaplastic / diagnosis*
  • Lymphoma, Large-Cell, Anaplastic / metabolism
  • Lymphoma, Large-Cell, Anaplastic / ultrastructure
  • Skin / pathology
  • Skin Neoplasms / pathology*
  • Treatment Outcome

Substances

  • Aromatase Inhibitors
  • Ki-67 Antigen
  • Anaplastic Lymphoma Kinase